Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127984031 | 12798403 | 1 | I | 20160927 | 0 | 20160930 | 20160930 | DIR | US-FDA-351899 | FDA-CTU | 59.71 | YR | F | N | 105.30000 | KG | 20160930 | N | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127984031 | 12798403 | 1 | PS | CHANTIX | VARENICLINE TARTRATE | 1 | Oral | ? QUANTITY:1 TABLET(S);? | N | 0 | BID | ||||||||
127984031 | 12798403 | 2 | C | ALEVE | NAPROXEN SODIUM | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127984031 | 12798403 | 1 | Smoking cessation therapy |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127984031 | 12798403 | Abnormal dreams | |
127984031 | 12798403 | Anger | |
127984031 | 12798403 | Anxiety | |
127984031 | 12798403 | Emotional disorder | |
127984031 | 12798403 | Feeling abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127984031 | 12798403 | 1 | 20160729 | 20160922 | 0 |